Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial

Archives of Gynecology and Obstetrics

Volumn 290, Issue 4, 2014, Pages 757-762

  Gomaa, Mostafa F ^a   Elkholy, Abdellatif G ^a   El Said, Mourrad M ^a   Abdel Salam, Nermine E ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

CD16; Heparin; Natural killer cells; Prednisolone; Recurrent miscarriage

Indexed keywords

ACETYLSALICYLIC ACID; CD56 ANTIGEN; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; FIBRINOLYTIC AGENT; GLUCOCORTICOID; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HEPARIN; NCAM1 PROTEIN, HUMAN; PREDNISOLONE;

ABORTION, HABITUAL; ADULT; BLOOD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECTS; FEMALE; HUMAN; NATURAL KILLER CELL; ORAL DRUG ADMINISTRATION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ABORTION, HABITUAL; ADMINISTRATION, ORAL; ADULT; ANTIGENS, CD56; ASPIRIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; GLUCOCORTICOIDS; GPI-LINKED PROTEINS; HEPARIN; HUMANS; KILLER CELLS, NATURAL; PREDNISOLONE; PREGNANCY; RECEPTORS, IGG; YOUNG ADULT;

EID: 84921984873     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3262-0     Document Type: Article

References (28)

1. Practice Committee of the American Society for Reproductive Medicine (2008) Definitions of infertility and recurrent pregnancy loss. Fertil Steril 89:1603
2. Egozcue S, Balanco J, Vendrell JM (2000) Human male infertility: chromosomal abnormalities, meiotic disorders, abnormal spermatozoa and recurrent abortion. Hum Reprod 6:9–105
3. Regan L, Jivraj S (2001) Infection and pregnancy loss. In: MacLean A, Regan L, Carrington D (eds) Infection and pregnancy. RCOG Press, London, pp 291–304
4. Wilcox AJ, Weinberg CR, O’Connor JF (1988) Incidence of early loss of pregnancy. N Engl J Med 319:189–194
5. Bricker L, Farquharson RG (2002) Types of pregnancy loss in recurrent miscarriage: implications for research and clinical practice. Hum Reprod 17:1345–1350
6. Rai R, Regan L (2006) Recurent miscarriage. Lancet 368:601–611
7. Hill JA (1999) Recurrent pregnancy loss. In: Rayan KJ., Berkowitz RS., Barbieri RL., Dunaif A. (eds), Kistner’s gynecology and women’s health, 7th edition. Mosby, St Louis pp 396
8. Summers PR (1994) Microbiology relevant to recurrent miscarriage. Clin Obstet Gynecol 37:722–729
9. Matovina M, Husnjak K, Milutin N, Ciglar S, Grce M (2004) Possible role of bacterial and viral infections in miscarriages. Fertil Steril 81:662–669
10. Abramson J, Stagnaro-Green A (2001) Thyroid antibodies and fetal loss: an evolving story. Thyroid 11:57–63
11. Moffett-King A (2002) Natural Killer cells and pregnancy. Nat Rev Immunol 2:656–663
12. Yovel G, Shakhar K, Ben-Eliyahu S (2001) The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol 81:254–262
13. Lee RM, Silver RM (2000) Recurrent pregnancy loss: summary and clinical recommendations. Semin Reprod Med 18:433–440
14. Royal College of Obstetricians and Gynaecologists (2003) Guideline no. 17. The management of recurrent miscarriage. RCOG press, London, p 22
15. American College of Obstetricians and Gynecologists (2002) Management of recurrent early pregnancy loss. ACOG practice bulletin. Int J Gynaecol Obstet 78:179–190
16. Bansal AS (2010) Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol 64:307–315
17. Thum M, Bhaskaran S, Abdallah HI, Ford B, Sumar N, Bansal AS (2008) Prednisolone suppresses NK cell cytotoxicity in vitro in women with a history of infertility and elevated NK cell cytotoxicity. Am J Reprod Immunol 59:259–265
18. Lash GE, Robson SC, Bulmer JN (2011) Functional role of uterine natural killer (uNK) cells in human early pregnancy deciduas. Placenta 31:S87–S92
19. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N (1995) Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 345:1340–1342
20. Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten L (2000) Peripheral natural killer cytotoxicity and CD 56(pos) CD16 (pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 15:1163–1169
21. + population. Dev Immunol 1:169–190
22. Nagler A, Lanier LL, Cwirla S, Phillips JH (1989) Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 143:3183–3191
23. Chrysoula D, Linda CG (2005) Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocrine Rev 26:44–62
24. Badawy AM, Khairy M, Sherif LS, Hassan M, Ragab A, Abdelall I (2008) Low- molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. J obstet and gynaecol 28:280–284
25. Fawzy M, Shokeir T, El-Tongy M, Warda O, El-Refaiey A, Mosbah A (2008) Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet 278:33–38
26. + NK) cells, B cells and T cells have no predictive value in IVF treatment outcome. Hum Reprod 20:1272–1276
27. Gilman-Sachs A, Duchateau BK, AslaKson CJ, Wohlgmuth GP, Kwak JY, Beer AE, Beaman KD (1999) Natural Killer (NK) cell subsets and NK cell cytotoxicity in women with histories of recurrent spontaneous abortions. Am J Reprod Immunol 41:99–105
28. Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S (2013) A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod 28:1743–1752